OATP Family Members as Cancer Biomarkers
Author Information
Author(s): Heather Pressler, Tristan M. Sissung, David Venzon, Douglas K. Price, William D. Figg
Primary Institution: National Cancer Institute
Hypothesis
Can OATP family members serve as biomarkers for hormone-related cancers?
Conclusion
OATP family members are correlated with differentiation in certain hormone-dependent cancers and may be useful as biomarkers for assessing clinical treatment and disease stage.
Supporting Evidence
- SLCO1B3 was expressed in 52% of cancerous prostate samples.
- SLCO2B1 had a higher frequency in thyroid cancer (67%) than normal (0%).
- SLCO1B1 expression was lower in liver cancer and trended lower with liver cancer grade.
Takeaway
This study looked at how certain proteins related to cancer might help doctors understand how serious the cancer is and how to treat it.
Methodology
The study analyzed mRNA expression of OATP family members in 381 patient samples from various cancers and normal tissues.
Potential Biases
Potential for false positives due to exploratory nature of the study.
Limitations
Low positive tumors for several sample sets limited complex analysis on differentiation and expression.
Participant Demographics
Mixed age and clinical diagnosis from various tumor stages.
Statistical Information
P-Value
p<0.05
Confidence Interval
95% CI
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website